Trials / Completed
CompletedNCT02799121
A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Avita Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective case series is to gain additional clinical experience in the treatment of diabetic foot ulcers, by documenting and relating patient history (including baseline wound characteristics) and clinical outcomes (incidence of healing, rate of healing, and patient and physician satisfaction) in a group of study participants for whom the ReGenerCell™ Autologous Cell Harvesting Device (ReGenerCell™) is used in combination with conventional therapy for the closure of diabetic foot ulcers (DFUs). Participants will receive ReGenerCell™ treatment in addition to standard care (debridement, cleansing, dressings, offloading).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ReGenerCell™ Autologous Cell Harvesting Device |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2019-03-29
- Completion
- 2019-03-29
- First posted
- 2016-06-14
- Last updated
- 2019-06-21
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02799121. Inclusion in this directory is not an endorsement.